Published this week in The Lancet Diabetes & Endocrinology , the research findings looked at 11 large-scale trials investigating seven medications in the GLP-1 receptor agonist class, including semaglutide (sold as Ozempic or Wegovy), dulaglutide (sold as Trulicity), and liraglutide (sold as Victoza)
The 10 million times claim is almost certainly hype
One percentage cannot prove all four identities, separate quantities, copper coordination, ratio, aggregation, uniformity or stability
Obviously with that, with people that aren't type two diabetic are or anything sit there and go 'oh cool, we can use this to just help people lose weight,' Wiens
Covering both unreconstituted lyophilised powder and reconstituted liquid forms
Henry Gregg, chief executive of the National Pharmacy Association, described the guidance as game changing and called for community pharmacy to be used in the deployment of weight-loss medication